您好，欢迎访问山东省农业科学院文献资源数据库平台

Antibiotic resistance and drug modification: Synthesis, characterization and bioactivity of newly modified potent pleuromutilin derivatives with a substituted piperazine moiety

文献类型： 外文期刊

作者： Yi, Yunpeng 1 ; Yang, Shifa 1 ; Liu, Yueyue 1 ; Yin, Bin 1 ; Zhao, Zengcheng 1 ; Li, Guiming 1 ; Huang, Zhongli 1 ; Chen, Lei 2 ; Liu, Fei 3 ; Shang, Ruofeng 4 ; Lin, Shuqian 1 ;

作者机构： 1.Shandong Acad Agr Sci, Inst Poultry Sci, Shandong Prov Anim & Poultry Green Hlth Prod Creat, 202 Gongyebeilu, Jinan 250023, Shandong, Peoples R China

2.Shandong Normal Univ, Coll Life Sci, Shandong Prov Key Lab Anim Resistance Biol, Jinan 250014, Shandong, Peoples R China

3.Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Shandong Key Lab Anim Dis Control & Breeding, Jinan 250023, Shandong, Peoples R China

4.Minist Agr & Rural Affairs, Lanzhou Inst Husb & Pharmaceut Sci CAAS, Key Lab New Anim Drug Project, Gansu Prov Key Lab Vet Pharmaceut Dev, Lanzhou 730050, Peoples R China

5.Lanzhou Inst Husb & Pharmaceut Sci CAAS, 335 Jiangouyan, Lanzhou 730050, Gansu, Peoples R China

关键词： Pleuromutilin derivatives; Synthesis; Antibacterial activity; Molecular docking

期刊名称：BIOORGANIC CHEMISTRY （ 影响因子：5.1； 五年影响因子：5.3 ）

ISSN： 0045-2068

年卷期： 2023 年 132 卷

页码：

收录情况： SCI

摘要： Antibiotic-resistant bacteria pose a major global public health concern, owing to the lack of effective antibac-terial drugs. Consequently, the discovery and development of innovative antibacterial drug classes with unique mechanisms of action are urgently needed. In this study, we designed, synthesised, and tested a series of novel pleuromutilin derivatives with piperazine linker substituted by amino acids moieties to determine their anti-bacterial properties. Most synthesized compounds exhibited potent activities against Staphylococcus aureus (S. aureus), methicillin-resistant S. aureus (MRSA), and methicillin-resistant Staphylococcus epidermidis. Com-pound 6l, the most potent antibacterial agent created in this study, displayed a rapid bactericidal activity against MRSA, Klebsiella pneumoniae and S. aureus cfr N12. Moreover, pharmacokinetics study of compound 6l exhibited good PK performance with a low in vivo clearance (CL = 1965 mL/h/kg) and a suitable half-life (T1/2 = 11.614 +/- 5.123 h). Molecular docking experiments revealed the binding model of compound 6l to the unmethylated A2503 of peptidyl transferase centre of 23S rRNA. Interaction pattern of 6l with cfr-mediated ribosomes revealed by molecular dynamics. Moreover in vivo mouse systemic infection experiments with compound 6l revealed its effectiveness against MRSA and S. aureus cfr N12 with the ED50 of 11.08 mg/kg and 14.63 mg/kg body weight, respectively.

  • 相关文献
作者其他论文 更多>>
置顶
购物车
反馈

© 京ICP备09089781号-29 主办单位：山东省农业科学院文献资源数据库平台

学术资源： 中国农业科学院 农业专业知识服务系统 农科联盟资源共建共享平台 中国农业科技文献与信息服务平台 中国农业期刊集成服务平台